MYRIAD GENETICS INC
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset,… (via Wikipedia)
Market & Alt Data
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | 2026-05-14 | Bisaro Paul | Director | Purchase | 7,500 | $3.69 | $28K | 97.4K | View | |
| 2026-03-09 | 2026-03-09 | Raha Samraat S. | Director & President and CEO | Purchase | 40.0K | $5.00 | $200K | 493.1K | View | |
| 2026-02-27 | 2026-02-27 | Phanstiel S. Louise | Director | Purchase | 48.0K | $4.66 | $224K | 282.0K | View | |
| 2026-02-26 | 2026-02-27 | Phanstiel S. Louise | Director | Purchase | 50.4K | $4.80 | $242K | 234.0K | View | |
| 2026-02-25 | 2026-02-27 | Phanstiel S. Louise | Director | Purchase | 6,100 | $4.74 | $29K | 183.5K | View |
Informational purposes only, not investment advice.
tormere.com/research/MYGN · generated 2026-10-28
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset,…
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-05-14 | Bisaro Paul | P | 7,500 | $27,637.5 |
| 2026-03-09 | Raha Samraat S. | P | 40,000 | $199,844 |
| 2026-02-27 | Phanstiel S. Louise | P | 48,000 | $223,728 |
| 2026-02-26 | Phanstiel S. Louise | P | 50,407 | $242,104.82 |
| 2026-02-25 | Phanstiel S. Louise | P | 6,100 | $28,889.6 |
Tormere — informational purposes only, not investment advice.